Emphysema due to α-antitrypsin deficiency: Familial study of the YBARCELONA variant

Chest

Volumn 124, Issue 1, 2003, Pages 404-406

  Miravitlles, Marc ^a,c   Vilà, Sara ^a   Jardí, Rosendo ^b   De La Roza, Cristian ^a   Rodríguez Frías, Francisco ^b   Vidal, Rafael ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Pulmonary emphysema; YBARCELONA; 1 antitrypsin deficiency

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 1 ANTITRYPSIN YBARCELONA; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ALPHA ANTITRYPSIN DEFICIENCY; ANAMNESIS; ARTICLE; BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; CODON; DISEASE CARRIER; EMPHYSEMA; EXON; FEMALE; FOLLOW UP; GENOME ANALYSIS; GENOTYPE; HUMAN; INHERITANCE; LABORATORY TEST; LUNG FUNCTION TEST; NEPHELOMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN VARIANT; RISK FACTOR; SMOKING;

EID: 0038826733     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.1.404     Document Type: Article

References (14)

1. Jarí R, Rodríguez-Frías F, Miravitlles M, et al. Identification and molecular characterization of the new α-1-antitrypsin deficient allele PI Ybarcelona (Asp256 to Val and Pro391 to His). Mutation in brief no. 174. Hum Mutat 1998; 12:213. Available at: http://interscience.wiley.com. Accessed March 24, 2003
2. Vidal R, Miravitlles M, Torrella M, et al. Estudio de la freeueneia de los diferentes fenotipos de alfa-1-antitripsina en la población de Barcelona. Med Clin (Bare) 1996; 107:211-214
3. 1-Antitrypsin: evidence of fifth PIM subtype and a new deficiency allele P I*Z Augsburg. Hum Cenet 1985; 71:27-29
4. Rodriguez F, Buti M, Jardi R, et al. Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations. Hepatology 1995; 22:1641-1647
5. Long G, Chandra T, Woo S, et al. Complete sequence of the cDNA for human α-1-antitrypsin and the gene for S variant. Biochemistry 1984; 23:4828-4837
6. Pierce JA. Antitrypsin and emphysema: perspective and prospects. JAMA 1988; 259:2890-2895
7. 1-antitrypsin gene and its mutations: clinical consequences and strategies for therapy. Chest 1989; 95:196-208
8. Jardí R, Rodríguez-Frías F, Casas F, et al. Caracterización molecular de 2 variantes deficitarias de la alfa-1-antitripsina: PI Mpdermo y PI Plovel. Med Clin (Barc) 1997; 109:463-466
9. Dahl M, Tybjarg-Hansen A, Lange P, et al. Change in lung function and morbidity from chronic obstructive pulmonary disease in α-1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 2002; 136:270-279
10. 1-Antitrypsin deficiency: incidence and detection program. Respir Med 2000; (Suppl C):S18-S21
11. 1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood specimens. Am J Respir Crit Care Med 2002; 166:814-817
12. 1-antitrypsin deficiency: the Spanish experience. Respir Med 1998; 92:1181-1187
13. Miravitlles M, Vidal R, Barros-Tizón JC, et al. Estado actual del tratamiento sustitutivo en el enfisema congénito por déficit de alfa-1-antitripsina. Arch Bronconeumol 1999; 35:446-454
14. Wencker M, for the International Registry of Alpha-1-antitripsin Deficiency. New formation of the International Registry on Alpha-1-Antitrypsin Deficiency as a joint database of multiple national registries [abstract]. Eur Respir J 1998; 12(suppl 28):382s